Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Recursion Pharmaceuticals, Inc. (RXRX)  
$8.59 0.20 (2.28%) as of 4:30 Wed 5/8


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 208,280,000
Market Cap: 1.79(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $5.09 - $15.86
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, in vivo validation capabilities and a cross-functional team to discover medicines. Co.'s potential medicines include: REC-994 for the treatment of cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 for the treatment of familial adenomatous polyposis; REC-3599 for the treatment of GM2 gangliosidosis; REC-3964 for the treatment of C. difficile colitis; REC-64917 for neural or systemic inflammation; and multiple simultaneous programs in fibrosis developing with Bayer AG.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 1,693,990
Total Buy Value $0 $0 $0 $12,897,789
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 27
Total Shares Sold 617,946 1,157,429 2,181,946 3,000,646
Total Sell Value $5,972,232 $10,903,828 $21,444,464 $28,622,080
Total People Sold 4 7 8 8
Total Sell Transactions 25 50 97 148
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 618
  Page 2 of 25  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Borgeson Blake Director   –       •      –    2024-03-19 4 AS $10.79 $216,423 D/D (20,054) 7,252,755 -18%     
   Secora Michael Chief Financial Officer   •       –      –    2024-03-13 4 AS $11.03 $275,815 D/D (25,000) 1,204,179 -19%     
   Secora Michael Chief Financial Officer   •       –      –    2024-03-13 4 OE $2.22 $83,250 D/D 37,500 1,229,179     -
   Secora Michael Chief Financial Officer   •       –      –    2024-03-12 4 AS $10.46 $261,375 D/D (25,000) 1,191,679 -16%     
   Secora Michael Chief Financial Officer   •       –      –    2024-03-12 4 OE $2.22 $83,250 D/D 37,500 1,216,679     -
   Gibson Christopher Chief Executive Officer   •       •      –    2024-03-06 4 AS $11.55 $288,823 I/I (25,000) 0 -22%     
   Gibson Christopher Chief Executive Officer   •       •      –    2024-03-06 4 A $0.00 $0 I/I 25,000 1,000     -
   Gibson Christopher Chief Executive Officer   •       •      –    2024-03-06 4 AS $11.86 $430,682 D/D (36,319) 1,108,524 -22%     
   Gibson Christopher Chief Executive Officer   •       •      –    2024-03-06 4 OE $2.48 $176,384 D/D 39,924 1,144,843     -
   Gibson Christopher Chief Executive Officer   •       •      –    2024-03-06 4 GD $0.00 $0 D/D 10,000 1,104,919     -
   Gibson Christopher Chief Executive Officer   •       •      –    2024-03-06 4 A $0.00 $0 D/D 10,000 1,114,919     -
   Borgeson Blake Director   –       •      –    2024-03-05 4 AS $12.06 $241,805 D/D (20,054) 7,272,809 -26%     
   Larson Tina Marriott President and COO   •       –      –    2024-02-22 4 AS $14.90 $119,160 D/D (8,000) 639,982 -41%     
   Larson Tina Marriott President and COO   •       –      –    2024-02-22 4 OE $1.06 $8,480 D/D 8,000 647,982     -
   Borgeson Blake Director   –       •      –    2024-02-20 4 AS $12.31 $247,125 D/D (20,054) 7,292,863 -30%     
   Larson Tina Marriott President and COO   •       –      –    2024-02-15 4 D $12.43 $66,861 D/D (5,379) 639,982     -
   Gibson Christopher Chief Executive Officer   •       •      –    2024-02-15 4 D $12.43 $138,570 D/D (11,148) 1,104,919     -
   Secora Michael Chief Financial Officer   •       –      –    2024-02-15 4 D $12.43 $89,148 D/D (7,172) 1,179,179     -
   Secora Michael Chief Financial Officer   •       –      –    2024-02-14 4 AS $10.43 $261,425 D/D (25,000) 1,186,351 -19%     
   Secora Michael Chief Financial Officer   •       –      –    2024-02-14 4 OE $2.22 $83,250 D/D 37,500 1,211,351     -
   Secora Michael Chief Financial Officer   •       –      –    2024-02-13 4 AS $9.86 $246,560 D/D (25,000) 1,173,851 -10%     
   Secora Michael Chief Financial Officer   •       –      –    2024-02-13 4 OE $2.22 $83,250 D/D 37,500 1,198,851     -
   Gibson Christopher Chief Executive Officer   •       •      –    2024-02-09 4 D $10.09 $32,621 D/D (3,233) 1,116,067     -
   Gibson Christopher Chief Executive Officer   •       •      –    2024-02-09 4 A $0.00 $0 D/D 344,597 1,119,300     -
   Mauro David J Chief Medical Officer   •       –      –    2024-02-09 4 D $10.09 $19,090 D/D (1,892) 244,629     -
  618 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 25
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us